Perpetual is arguably worth $30 a share and potentially more over time. This is why we have seen so many bids for the ...

Below is a summary of the topics we covered on Nucleus Investment Insights this month. See the links for more information.

Although RMD has re-rated from its share price low of around $21.50 in October 2023, it has only just surpassed its all-time ...

Tech selloff, Fed holds rates, Aussie inflation cools—markets brace for February.

Joe McCarthy from Elston and David Wilson from First Sentier run the ruler over your most-tipped growth stocks for 2025 ...

Russia's invasion of Ukraine has untethered gold's correlation to real interest rates and threatens to extend an ongoing bull ...

The prospect of the new Trump administration raising tariffs may have helped push up interest rate expectations, bond yields, ...

That's because the Australian Dollar Trade Weighted Index (A$ TWI) is now below 60%. On a 12-month view, Nicol says "that ...

Stellar performance leads to swathe of glowing research notes. Plus, Pilbara chief cites ‘incredibly strong’ long-term ...

We discuss our stock picks from 2024 and then highlight three new high-quality companies best placed to navigate 2025.

The transformational merger of Chemist Warehouse Group and Sigma Healthcare has cleared the final hurdles, with both Sigma ...

A bull market in stocks will spill into strong results for fund managers, as investors wait to pounce on a rotation from ...